These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23249450)

  • 41. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction.
    Zhang D; Yang X; Li J; Yu J; Wu X
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):440-448. PubMed ID: 31222771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Relationship between Polycystic Ovary Syndrome and Serum Periostin Level.
    Gonulalan G; Guney I; Sackan F; Acar S
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1291-1295. PubMed ID: 34689485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
    Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
    J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.
    Glueck CJ; Morrison JA; Goldenberg N; Wang P
    Metabolism; 2009 May; 58(5):714-21. PubMed ID: 19375597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.
    Karthik S; Vipin VP; Kapoor A; Tripathi A; Shukla M; Dabadghao P
    Hum Reprod; 2019 Aug; 34(8):1559-1566. PubMed ID: 31299073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
    Zhang J; Chen L; Ye J
    Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index.
    Garoufi A; Pagoni A; Papadaki M; Marmarinos A; Karapostolakis G; Michala L; Soldatou A
    Children (Basel); 2021 Dec; 9(1):. PubMed ID: 35053629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome.
    Doğanay M; Ozyer SS; Var T; Tonguc E; Gun Eryilmaz O; Ozer I; Guzel AI
    Arch Gynecol Obstet; 2015 Feb; 291(2):447-50. PubMed ID: 25138125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
    Ezeh U; Ida Chen YD; Azziz R
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):163-172. PubMed ID: 32286715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z; Krstevska B
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.